Cargando…

A comparative analysis of epidemiological characteristics of MERS-CoV and SARS-CoV-2 in Saudi Arabia

In this study, we determine and compare the incubation duration, serial interval, pre-symptomatic transmission, and case fatality rate of MERS-CoV and COVID-19 in Saudi Arabia based on contact tracing data we acquired in Saudi Arabia. The date of infection and infector-infectee pairings are deduced...

Descripción completa

Detalles Bibliográficos
Autores principales: Althobaity, Yehya, Wu, Jianhong, Tildesley, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343745/
https://www.ncbi.nlm.nih.gov/pubmed/35938094
http://dx.doi.org/10.1016/j.idm.2022.07.002
_version_ 1784761057701527552
author Althobaity, Yehya
Wu, Jianhong
Tildesley, Michael J.
author_facet Althobaity, Yehya
Wu, Jianhong
Tildesley, Michael J.
author_sort Althobaity, Yehya
collection PubMed
description In this study, we determine and compare the incubation duration, serial interval, pre-symptomatic transmission, and case fatality rate of MERS-CoV and COVID-19 in Saudi Arabia based on contact tracing data we acquired in Saudi Arabia. The date of infection and infector-infectee pairings are deduced from travel history to Saudi Arabia or exposure to confirmed cases. The incubation times and serial intervals are estimated using parametric models accounting for exposure interval censoring. Our estimations show that MERS-CoV has a mean incubation time of 7.21 (95% CI: 6.59–7.85) days, whereas COVID-19 (for the circulating strain in the study period) has a mean incubation period of 5.43(95% CI: 4.81–6.11) days. MERS-CoV has an estimated serial interval of 14.13(95% CI: 13.9–14.7) days, while COVID-19 has an estimated serial interval of 5.1(95% CI: 5.0–5.5) days. The COVID-19 serial interval is found to be shorter than the incubation time, indicating that pre-symptomatic transmission may occur in a significant fraction of transmission events. We conclude that during the COVID-19 wave studied, at least 75% of transmission happened prior to the onset of symptoms. The CFR for MERS-CoV is estimated to be 38.1% (95% CI: 36.8–39.5), while the CFR for COVID-19 1.67% (95% CI: 1.63–1.71). This work is expected to help design future surveillance and intervention program targeted at specific respiratory virus outbreaks, and have implications for contingency planning for future coronavirus outbreaks.
format Online
Article
Text
id pubmed-9343745
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher KeAi Publishing
record_format MEDLINE/PubMed
spelling pubmed-93437452022-08-02 A comparative analysis of epidemiological characteristics of MERS-CoV and SARS-CoV-2 in Saudi Arabia Althobaity, Yehya Wu, Jianhong Tildesley, Michael J. Infect Dis Model Article In this study, we determine and compare the incubation duration, serial interval, pre-symptomatic transmission, and case fatality rate of MERS-CoV and COVID-19 in Saudi Arabia based on contact tracing data we acquired in Saudi Arabia. The date of infection and infector-infectee pairings are deduced from travel history to Saudi Arabia or exposure to confirmed cases. The incubation times and serial intervals are estimated using parametric models accounting for exposure interval censoring. Our estimations show that MERS-CoV has a mean incubation time of 7.21 (95% CI: 6.59–7.85) days, whereas COVID-19 (for the circulating strain in the study period) has a mean incubation period of 5.43(95% CI: 4.81–6.11) days. MERS-CoV has an estimated serial interval of 14.13(95% CI: 13.9–14.7) days, while COVID-19 has an estimated serial interval of 5.1(95% CI: 5.0–5.5) days. The COVID-19 serial interval is found to be shorter than the incubation time, indicating that pre-symptomatic transmission may occur in a significant fraction of transmission events. We conclude that during the COVID-19 wave studied, at least 75% of transmission happened prior to the onset of symptoms. The CFR for MERS-CoV is estimated to be 38.1% (95% CI: 36.8–39.5), while the CFR for COVID-19 1.67% (95% CI: 1.63–1.71). This work is expected to help design future surveillance and intervention program targeted at specific respiratory virus outbreaks, and have implications for contingency planning for future coronavirus outbreaks. KeAi Publishing 2022-08-02 /pmc/articles/PMC9343745/ /pubmed/35938094 http://dx.doi.org/10.1016/j.idm.2022.07.002 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Althobaity, Yehya
Wu, Jianhong
Tildesley, Michael J.
A comparative analysis of epidemiological characteristics of MERS-CoV and SARS-CoV-2 in Saudi Arabia
title A comparative analysis of epidemiological characteristics of MERS-CoV and SARS-CoV-2 in Saudi Arabia
title_full A comparative analysis of epidemiological characteristics of MERS-CoV and SARS-CoV-2 in Saudi Arabia
title_fullStr A comparative analysis of epidemiological characteristics of MERS-CoV and SARS-CoV-2 in Saudi Arabia
title_full_unstemmed A comparative analysis of epidemiological characteristics of MERS-CoV and SARS-CoV-2 in Saudi Arabia
title_short A comparative analysis of epidemiological characteristics of MERS-CoV and SARS-CoV-2 in Saudi Arabia
title_sort comparative analysis of epidemiological characteristics of mers-cov and sars-cov-2 in saudi arabia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343745/
https://www.ncbi.nlm.nih.gov/pubmed/35938094
http://dx.doi.org/10.1016/j.idm.2022.07.002
work_keys_str_mv AT althobaityyehya acomparativeanalysisofepidemiologicalcharacteristicsofmerscovandsarscov2insaudiarabia
AT wujianhong acomparativeanalysisofepidemiologicalcharacteristicsofmerscovandsarscov2insaudiarabia
AT tildesleymichaelj acomparativeanalysisofepidemiologicalcharacteristicsofmerscovandsarscov2insaudiarabia
AT althobaityyehya comparativeanalysisofepidemiologicalcharacteristicsofmerscovandsarscov2insaudiarabia
AT wujianhong comparativeanalysisofepidemiologicalcharacteristicsofmerscovandsarscov2insaudiarabia
AT tildesleymichaelj comparativeanalysisofepidemiologicalcharacteristicsofmerscovandsarscov2insaudiarabia